ArticlePrecision clinical medicine2026

Identification of factors conferring resistance to trastuzumab deruxtecan in advanced gastric cancer: a translational study from the single-arm, phase II, DESTINY-Gastric06 trial.

Bohan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.